IP Library Granted Patent US 10,641,591
Granted Patent B1
US 10,641,591 · App. 15/919,946 · Granted May 5, 2020

Biological active bullets, systems, and methods

Inventor: Darren Rubin (Largo, FL)
F42B12/54F42B12/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,641,591
App. No.
15/919,946
Granted
May 5, 2020
Kind
B1
Abstract

A bullet projectile, not limited to a hollow point bullet, is made into a biological active bullet before loading and firing from a firearm with a method of incorporating an at least one biological active payload into an at least one externally facing cavity or channel of the bullet projectile to enhance the damage and lethality of the bullet projectile to produce at least one of embolism, infarct, necrosis, hemorrhage, enhanced loss of perfusion, anticoagulation, or a combination thereof in a target.

Claims (17)

1. An at least one biological active payload structured to be inserted, twisted, stuffed, filled, or a combination thereof into an at least one externally exposed cavity/channel of a bullet projectile; said bullet projectile structured to be packaged in a cartridge/shell and structured to be discharged from a firearm to produce at least one bullet wound in a target; said at least one biological active payload being at least partially exposed to the external environment from said bullet projectile before said bullet projectile reaches said target so that said at least one biological active payload immediately comes in contact with a bodily fluid from said target upon impact and penetration of said bullet projectile; said at least one biological active payload enhancing damage/lethality of the at least one bullet wound by interacting with said bodily fluid of said target to produce at least one of embolism, infarct, necrosis, hemorrhage, enhanced loss of perfusion, anticoagulation, or a combination thereof.

2. The at least one biological active payload as set forth in claim 1 comprising at least one embolus.

3. The at least one biological active payload as set forth in claim 1 comprising at least one gas bubble producing material/substance.

4. The at least one biological active payload as set forth in claim 1 comprising at least one coagulant that causes an embolism/pulmonary embolism in said target.

5. The at least one biological active payload as set forth in claim 1 comprising at least one antigen/superantigen that causes anaphylactic shock in said target.

6. The at least one biological active payload as set forth in claim 1 comprising at least one anticoagulant.

7. The at least one biological active payload as set forth in claim 1 comprising at least one anticoagulant that hastens and increases excessive blood loss/bleed out from the bullet wound.

8. The at least one biological active payload as set forth in claim 1 comprising at least one toxin selected from silica/silicate-containing minerals, synthetic vitreous fibers, asbestos, arsenic, arsenic-containing minerals/compounds, or a combination thereof.

9. The at least one biological active payload as set forth in claim 1 further associated with an at least one adhesive.

10. The at least one biological active payload as set forth in claim 1 further completing a continuous surface or ogive shape of said bullet projectile.

11. A method of transforming a bullet projectile into a biological active bullet projectile before loading and firing from a firearm by inserting, twisting, stuffing, filling, or a combination thereof, an at least one biological active payload as described in claim 1 into an at least one externally facing cavity/channel of said bullet projectile.

12. A method of transforming a payload housing into a biological active payload described in claim 1 by filling/associating said payload housing with a biological active material/substance.

13. An at least one payload housing structured to be inserted, twisted, stuffed, filled or a combination thereof into an at least one externally exposed cavity/channel of a bullet projectile; said bullet projectile structured to be packaged in a cartridge/shell and structured to be discharged from a firearm to produce at least one bullet wound in a target; said at least one payload housing filled/associated with a biological active material/substance to form an at least one biological active payload; said at least one biological active payload being at least partially exposed to the external environment from said bullet projectile before said bullet projectile reaches said target so that said at least one biological active payload immediately comes in contact with a bodily fluid from said target upon impact and penetration of said bullet projectile; said at least one biological active payload enhancing damage/lethality of the at least one bullet wound by interacting with said bodily fluid of said target thereof.

14. The at least one biological active payload as set forth in claim 13 producing at least one of embolism, infarct, necrosis, hemorrhage, enhanced loss of perfusion, anticoagulation, or a combination thereof, after interacting with said bodily fluid of said target.

15. The at least one biological active material/substance as set forth in claim 13 comprising at least one material/substance selected from emboli, gas bubble producing materials/substances, toxins, antigens, coagulants, anticoagulants, or a combination thereof.

16. The at least one biological active payload as set forth in claim 13 further associated with an at least one adhesive.

17. A method of transforming a bullet projectile into a biological active bullet projectile before loading and firing from a firearm by first filling/associating an at least one payload housing with a biological active material/substance to form a biological active payload as described in claim 13 , and next inserting, twisting, stuffing, filling, or a combination thereof, said biological active payload into an at least one externally facing cavity/channel of said bullet projectile.

Continuity (3)
Continuation In Part 15193801 · Jun 27, 2016
Continuation In Part 14615671 · Feb 6, 2015
Continuation In Part 13461863 · May 2, 2012
Cited By (1)
US 12,339,106